MX2022009036A - Colageno dietetico no de animales. - Google Patents
Colageno dietetico no de animales.Info
- Publication number
- MX2022009036A MX2022009036A MX2022009036A MX2022009036A MX2022009036A MX 2022009036 A MX2022009036 A MX 2022009036A MX 2022009036 A MX2022009036 A MX 2022009036A MX 2022009036 A MX2022009036 A MX 2022009036A MX 2022009036 A MX2022009036 A MX 2022009036A
- Authority
- MX
- Mexico
- Prior art keywords
- collagen
- animal
- naturally occurring
- occurring polypeptides
- free dietary
- Prior art date
Links
- 102000008186 Collagen Human genes 0.000 title abstract 2
- 108010035532 Collagen Proteins 0.000 title abstract 2
- 229920001436 collagen Polymers 0.000 title abstract 2
- 235000005911 diet Nutrition 0.000 title 1
- 230000000378 dietary effect Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
- A21D2/261—Animal proteins
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
- A21D2/264—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/002—Preparations for repairing the hair, e.g. hair cure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/008—Preparations for oily hair
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/195—Proteins from microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Rheumatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
Abstract
En la presente se proporcionan polipéptidos de origen no natural que comprenden una secuencia de un fragmento de un colágeno y células recombinantes que contienen secuencias de ácido nucleico heterólogas que codifica paran para para los polipéptidos de origen no natural. Además, en la presente se proporcionan métodos no de animales para generar y purificar estos polipéptidos de origen no natural usando microorganismos, preferiblemente de células bacterianas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202062965700P | 2020-01-24 | 2020-01-24 | |
US202063117243P | 2020-11-23 | 2020-11-23 | |
PCT/US2021/014714 WO2021150959A1 (en) | 2020-01-24 | 2021-01-22 | Animal-free dietary collagen |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022009036A true MX2022009036A (es) | 2022-11-14 |
Family
ID=76991717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022009036A MX2022009036A (es) | 2020-01-24 | 2021-01-22 | Colageno dietetico no de animales. |
Country Status (11)
Country | Link |
---|---|
US (3) | US11174300B2 (es) |
EP (1) | EP4093761A4 (es) |
JP (1) | JP2023513435A (es) |
CN (1) | CN115298212A (es) |
AU (1) | AU2021211721A1 (es) |
BR (1) | BR112022014586A2 (es) |
CA (1) | CA3168802A1 (es) |
GB (1) | GB2610313A (es) |
MX (1) | MX2022009036A (es) |
TW (1) | TW202134267A (es) |
WO (1) | WO2021150959A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2022009036A (es) | 2020-01-24 | 2022-11-14 | Geltor Inc | Colageno dietetico no de animales. |
WO2023009656A1 (en) * | 2021-07-28 | 2023-02-02 | Geltor, Inc. | Pharmaceutical compositions and methods for treating connective tissue conditions with collagen polypeptides |
KR20240039023A (ko) * | 2021-07-28 | 2024-03-26 | 젤터, 인코포레이티드 | 동물 유래 물질이 없는 화장용 콜라겐 |
Family Cites Families (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6653450B1 (en) | 1993-01-28 | 2003-11-25 | Cohesion Technologies, Inc. | Mutated recombinant collagens |
WO1997038710A1 (en) | 1996-04-12 | 1997-10-23 | Fibrogen, Inc. | Synthesis of human procollagens and collagens in recombinant dna systems |
FR2757874B1 (fr) | 1996-12-17 | 2003-04-25 | Biocem | Collagenes recombinants et proteines derivees produits par les plantes, leurs procedes d'obtention et leurs utilisations |
AUPO811797A0 (en) | 1997-07-18 | 1997-08-14 | University Of Sydney, The | Tropoelastin derivatives |
US6428978B1 (en) | 1998-05-08 | 2002-08-06 | Cohesion Technologies, Inc. | Methods for the production of gelatin and full-length triple helical collagen in recombinant cells |
US6992172B1 (en) | 1999-11-12 | 2006-01-31 | Fibrogen, Inc. | Recombinant gelatins |
US6682760B2 (en) | 2000-04-18 | 2004-01-27 | Colbar R&D Ltd. | Cross-linked collagen matrices and methods for their preparation |
TW499433B (en) * | 2000-12-27 | 2002-08-21 | Ind Tech Res Inst | Novel human Α1-chain collagen |
CN1500876A (zh) * | 2002-11-14 | 2004-06-02 | �й������ž�����ҽѧ��ѧԺ����ҽ | 一种编码鸡ⅱ型胶原蛋白的全长多核苷酸序列及其用途 |
EP1584630A1 (en) | 2004-04-08 | 2005-10-12 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Method for preparing a modified protein outside a host cell |
US7932353B2 (en) | 2005-02-23 | 2011-04-26 | Fujifilm Manufacturing Europe B.V. | Non-glycosylated recombinant collagen-like polypeptides |
WO2006133107A2 (en) | 2005-06-03 | 2006-12-14 | The Texas A & M University System | Specific binding sites in collagen for integrins and use thereof |
WO2007044945A2 (en) | 2005-10-13 | 2007-04-19 | Gu, Jennifer, L. | Mineral collagen chelates and methods of making and using same |
US7279329B2 (en) | 2005-10-17 | 2007-10-09 | Industrial Technology Research Institute | Expression system for producing collagen |
US8841255B2 (en) | 2005-12-20 | 2014-09-23 | Duke University | Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides |
DE602006011791D1 (de) | 2006-03-13 | 2010-03-04 | Becker & Co Naturinwerk | Kollagenpulver und auf kollagen basierende thermoplastische zusammensetzung zur herstellung von formkörpern |
EP2054442A2 (en) * | 2006-06-14 | 2009-05-06 | Cell-Matrix, Inc. | Denatured collagen peptides and uses thereof |
EP2117620A4 (en) | 2006-09-29 | 2010-12-01 | Martin Kean Chong Ng | PROTOELASTINE BIOMATERIALS FROM TROOELASTINE |
EP2220246B1 (en) | 2007-10-26 | 2015-05-20 | Collplant Ltd. | Methods of processing recombinant procollagen |
US7910134B2 (en) | 2007-10-29 | 2011-03-22 | Ayman Boutros | Alloplastic injectable dermal filler and methods of use thereof |
US8507652B2 (en) | 2008-02-08 | 2013-08-13 | Luis Eduardo da Cruz | Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix |
GB0820784D0 (en) * | 2008-11-13 | 2008-12-24 | Nordic Bioscience As | Assessment of protein degradation by measurement of isomerised neo-epitope containing fragments |
US9382310B2 (en) | 2009-02-06 | 2016-07-05 | Rutgers, The State University Of New Jersey | Expression of triple-helical collagen-like products in E. coli |
EP3173792B1 (en) * | 2009-03-30 | 2019-06-12 | Nordic Bioscience A/S | Crp neo-epitope fibrosis assay |
EP2454367B1 (en) | 2009-07-17 | 2013-10-16 | The Texas A&M University System | Designer collagens and uses thereof |
US9402857B2 (en) | 2009-07-23 | 2016-08-02 | U.S. Nutraceuticals, LLC | Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin |
DE102010060564A1 (de) | 2010-11-15 | 2012-05-16 | Gelita Ag | Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel |
WO2012149136A1 (en) | 2011-04-26 | 2012-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Production and delivery of a stable collagen |
AU2012289916B2 (en) | 2011-08-03 | 2017-08-03 | Phoenix Tissue Repair, Inc. | Collagen 7 and related methods |
TWI592421B (zh) | 2011-08-09 | 2017-07-21 | 双美生物科技股份有限公司 | 一種三重交聯之膠原蛋白、製造方法及其用途 |
EP2758032B1 (en) | 2011-09-21 | 2021-10-27 | Shiseido Americas Corporation | Compositions and methods for treating conditions of compromised skin barrier function |
JP5992529B2 (ja) * | 2012-09-26 | 2016-09-14 | 富士フイルム株式会社 | ポリペプチド、足場組成物、軟骨組織修復用組成物、軟骨細胞培養用組成物及びグリコサミノグリカン産生促進用組成物 |
WO2014106830A1 (en) | 2013-01-07 | 2014-07-10 | Ramot At Tel-Aviv University Ltd. | Jellyfish-derived polymer |
BR112015023447A2 (pt) | 2013-03-21 | 2017-12-05 | Commw Scient Ind Res Org | purificação de proteínas helicoidais triplas |
WO2015031950A1 (en) | 2013-09-09 | 2015-03-12 | Commonwealth Scientific And Industrial Research Organisation | Modified bacterial collagen-like proteins |
AU2014324900A1 (en) | 2013-09-25 | 2016-05-19 | Axcella Health Inc. | Compositions and formulations for prevention and reduction of tumorigenesis, cancer cell proliferation and invasion, and methods of production and use thereof in cancer treatment |
US10232008B1 (en) | 2015-10-05 | 2019-03-19 | Michael P. Moran | Multi-purpose nutritional supplement composition |
AU2016354456B2 (en) | 2015-11-09 | 2022-02-17 | Shiseido Company, Ltd. | Compositions and methods for application over skin |
GB201601136D0 (en) | 2016-01-21 | 2016-03-09 | Mörgelin Matthias And Abdillahi Suado M | Novel polypeptides and medical uses thereof |
US10226550B2 (en) | 2016-03-11 | 2019-03-12 | Brigham Young University | Cationic steroidal antimicrobial compositions for the treatment of dermal tissue |
US10669327B2 (en) | 2016-03-16 | 2020-06-02 | Phoenix Tissue Repair, Inc. | Methods of purifying collagen 7 |
CN106554410B (zh) | 2016-06-02 | 2019-11-26 | 陕西东大生化科技有限责任公司 | 一种重组人源胶原蛋白及其编码基因和制备方法 |
CN106119322B (zh) | 2016-07-22 | 2019-10-15 | 江苏江山聚源生物技术有限公司 | 一种提高重组人源胶原蛋白生产水平的发酵工艺 |
KR20190042006A (ko) | 2016-08-30 | 2019-04-23 | 겔리타 아게 | 지구력 성능을 향상시키고 지질 이화작용을 자극하기 위한 콜라겐 가수분해물의 용도 |
FR3058142B1 (fr) | 2016-10-28 | 2023-11-24 | Gelatines Weishardt | Composition de peptides de collagene de peau de poisson et son utilisation a titre de medicament |
CL2016003387A1 (es) | 2016-12-29 | 2018-10-12 | Univ De Santiago De Chile Usach | Recubrimiento y/o película comestible para la conservación de productos cárneos |
WO2019023555A1 (en) | 2017-07-28 | 2019-01-31 | Evelo Biosciences, Inc. | POLYMER COMPOSITIONS |
WO2019046943A1 (en) | 2017-09-06 | 2019-03-14 | University Of Ottawa | PROTEINS OF THE COLLAGEN TYPE |
US11180541B2 (en) * | 2017-09-28 | 2021-11-23 | Geltor, Inc. | Recombinant collagen and elastin molecules and uses thereof |
GB201717134D0 (en) | 2017-10-18 | 2017-12-06 | Univ Swansea | Monomeric collagen |
IL274761B1 (en) * | 2017-11-22 | 2024-03-01 | Geltor Inc | Methods and systems for collagen engineering |
DE102018104590A1 (de) | 2018-02-28 | 2019-08-29 | Gelita Ag | Nutrazeutische oder pharmazeutische Zusammensetzung |
JP7317964B2 (ja) * | 2019-04-01 | 2023-07-31 | ジェルター, インコーポレイテッド | 組換えコラーゲンの局所製剤 |
US11666639B2 (en) | 2019-06-03 | 2023-06-06 | Societe Des Produits Nestle S.A. | Recovery dietary supplement |
MX2022009036A (es) | 2020-01-24 | 2022-11-14 | Geltor Inc | Colageno dietetico no de animales. |
-
2021
- 2021-01-22 MX MX2022009036A patent/MX2022009036A/es unknown
- 2021-01-22 AU AU2021211721A patent/AU2021211721A1/en active Pending
- 2021-01-22 EP EP21745159.0A patent/EP4093761A4/en active Pending
- 2021-01-22 TW TW110102587A patent/TW202134267A/zh unknown
- 2021-01-22 JP JP2022545046A patent/JP2023513435A/ja active Pending
- 2021-01-22 GB GB2212264.2A patent/GB2610313A/en active Pending
- 2021-01-22 BR BR112022014586A patent/BR112022014586A2/pt unknown
- 2021-01-22 WO PCT/US2021/014714 patent/WO2021150959A1/en unknown
- 2021-01-22 CA CA3168802A patent/CA3168802A1/en active Pending
- 2021-01-22 CN CN202180022766.8A patent/CN115298212A/zh active Pending
- 2021-02-09 US US17/171,874 patent/US11174300B2/en active Active
- 2021-10-04 US US17/493,627 patent/US11332505B2/en active Active
-
2022
- 2022-04-06 US US17/714,896 patent/US20220332775A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021150959A1 (en) | 2021-07-29 |
US20210277075A1 (en) | 2021-09-09 |
BR112022014586A2 (pt) | 2022-09-13 |
EP4093761A4 (en) | 2024-04-17 |
GB202212264D0 (en) | 2022-10-05 |
EP4093761A1 (en) | 2022-11-30 |
JP2023513435A (ja) | 2023-03-31 |
US11332505B2 (en) | 2022-05-17 |
TW202134267A (zh) | 2021-09-16 |
CA3168802A1 (en) | 2021-07-29 |
US11174300B2 (en) | 2021-11-16 |
CN115298212A (zh) | 2022-11-04 |
US20220017581A1 (en) | 2022-01-20 |
AU2021211721A1 (en) | 2022-08-18 |
GB2610313A (en) | 2023-03-01 |
US20220332775A1 (en) | 2022-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022009036A (es) | Colageno dietetico no de animales. | |
EP4272765A3 (en) | Adeno-associated virus (aav) clade f vector and uses therefor | |
HK1099938A1 (en) | Gene expression technique | |
PH12019501413A1 (en) | T-cell modulatory multimeric polypeptides and method of use thereof | |
IL86480A (en) | Recombinant dna coding for human proapolipoprotein a-1,expression vectors containing it and cells transformed by said expression vector | |
AR037583A1 (es) | Metodo para producir l-aminoacidos utilizando bacterias que pertenecen al genero escherichia | |
MXPA02006888A (es) | Flavivirus recombinantes y metodos para utilizar los mismos. | |
NZ603996A (en) | Cells or cell lines that stably express a bitter taste receptor and methods of making them | |
ES8504458A1 (es) | Procedimiento para producir la subunidad a la toxina del colera. | |
WO2003106684A3 (en) | PROCESS FOR THE SIMULTANEOUS PRODUCTION OF SEVERAL PROTEINS; VECTORS AND CELLS USED IN THIS PROCESS | |
AU2002251060A1 (en) | Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated dgsa gene | |
MX2010004397A (es) | Celula para uso en la produccion de proteina exogena y proceso de produccion que utiliza la celula. | |
SI1675956T1 (sl) | Minimalno zaporedje dna, ki deluje kot izolirni element kromatina in njegova uporaba pri ekspresiji proteinov | |
MX2012001672A (es) | Vector que comprende promotor de manosa y promotor de manosa. | |
MX2021000421A (es) | Métodos y composiciones que usan células dendríticas recombinantes para el tratamiento del cáncer. | |
MX2022004345A (es) | Construcciones de igf2 variantes. | |
GB0116460D0 (en) | Biological products | |
MX2022009200A (es) | Vectores a base de poxvirus producidos por acido desoxirribonucleico (adn) natural o sintetico y usos de los mismos. | |
MX2022000055A (es) | Enzimas de polimerización para reacciones de secuenciación. | |
TW200604207A (en) | A superantigen fusion protein and the use thereof | |
HUP0500349A2 (hu) | Eljárás polipeptidek előállítására | |
TW200639251A (en) | Novel method of producing high plants and method of accelerating growth of high plants | |
WO2022066975A3 (en) | GENETICALLY ENCODED CALCIUM INDICATORS (GECIs) AND METHODS OF MAKING AND USING | |
WO2023164646A3 (en) | Methods and compositions for treating cancer | |
WO2020077017A3 (en) | Methods for isolating immune binding proteins |